Trials / Completed
CompletedNCT02689999
The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Neutec Ar-Ge San ve Tic A.Ş · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
It is planned to investigate the effect of dexrabeprazole on gastric acid primarily, and then gastroesophageal reflux disease (GERD) symptoms, intraesophageal acidity (reflux) and impedance kinetics.
Detailed description
The participants will be on one week medication after two-weeks observation period. Intragastric and intraesophageal multichannel intraluminal impedance-pH (pH-MII) monitoring will be performed before and after medication. The pre- and post-treatment data will be compared. The safety tests will be performed during study in terms of possible side effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexrabeprazole 10 mg Enteric-Coated Tablets |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2017-05-01
- Completion
- 2017-08-01
- First posted
- 2016-02-24
- Last updated
- 2017-08-24
Locations
3 sites across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02689999. Inclusion in this directory is not an endorsement.